Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 12 Oct
Source: Bse
FMCG stocks · Large cap · NSE
Tata Consumer Products is an integrated F&B company, part of the Tata Group, aiming for a larger share of the FMCG market. It is India's largest salt brand, 2nd largest tea brand, and #1 natural mineral water brand. Globally, it is the #2 branded tea player and 4th largest R&G coffee brand in the USA.
SMA20 -4.8% / mo · MACD + · near 52W low · sector -5.7pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +11.9% · PAT +28.6% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +12% YoY · PAT +29% YoY · margin expansion · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹5,349 Cr | +11.9% | -1.6% |
| EBITDA | ₹724 Cr | +19.3% | -8.6% |
| Operating margin | 14.0% | +100 bps | -100 bps |
| PAT | ₹427 Cr | +28.6% | +0.7% |
| PAT margin | 8.0% | +103 bps | +18 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 21/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 45. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 31 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in FMCG — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Consolidated revenue grew 18% in Q4FY26 and 15% in FY26, driven by strong India business volume growth. Q4 EBITDA expanded 100bps to 14.6%, up 27% YoY, though FY26 EBITDA margin saw a slight contraction.
The company delivered robust top-line growth, particularly in India and its 'Growth' businesses, with strong Q4 EBITDA expansion. While India Tea revenue declined due to price pass-through, Salt and Sampann showed strong momentum. International and Non-branded segments had mixed profitability, with geopolitical issues impacting exports. Overall strategic priorities are progressing well.
Latest issuer-disclosed distribution across 2 reported categories.
'Growth' businesses crossed ₹4,000 crore revenue in FY26, growing 24% in FY26 and 33% in Q4FY26.
Tata Sampann recorded strong momentum, growing 69% in Q4FY26 and 46% in FY26, with broad-based contribution.
Salt delivered 14% revenue growth in FY26 to cross ₹4,000 crore, supported by double-digit volume growth.
The US business delivered 24% YoY growth in Q4FY26, driven by pricing actions, and 23% for the full year.
Tata Starbucks expanded its network with 23 net new store openings during FY26, reaching 502 total stores across 80 cities.
Tea prices in North India moderated in Q4FY26, witnessing a seasonal correction post earlier peaks.
Robusta prices softened sequentially in Q4FY26, with average prices at an 8-quarter low.
Capital Foods had a softer Q4FY26 due to export disruption from geopolitical developments, causing combined exports to decline 9%.
International EBITDA declined 6% (CC) YoY in Q4FY26, with margin 220 bps lower, driven by gross margin pressure.
Non-branded EBITDA declined 29% (CC) in Q4FY26, with margin contracting 1,280 bps due to reversal of prior-year fair value benefits.
The company's forward-looking statements acknowledge risks from commodity price fluctuations, which can impact input costs and pricing environment.
The disclaimer highlights competitive intensity as a factor that may affect actual results.
Geopolitical disruptions impacted Capital Foods' exports in Q4FY26, demonstrating vulnerability to global events.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The investor presentation primarily reports Q4FY26 results against Q4FY25 and full-year FY26 results against FY25. For a consumer business, year-on-year comparison is crucial to account for seasonality and provide a consistent view of performance trends.
Consolidated revenue grew 18% in Q4FY26 and 15% in FY26.
India business delivered 16% underlying volume growth in Q4FY26 and 13% in FY26.
Consolidated EBITDA grew 27% in Q4FY26, with margin expanding 100 bps to 14.6%. FY26 EBITDA grew 12% with margin at 13.9% (-30bps YoY).
India Tea volumes grew 4% in Q4FY26, but revenue marginally declined as lower input costs were passed on to consumers. FY26 revenue grew 6%.
Management aims to drive more focus on 'Growth' businesses in Tea and Salt dominant markets through a new GTM model.
The company is embracing Channels of the Future, with Modern Trade, E-commerce, Q-commerce, and Emerging Channels showing strong growth.
Management emphasizes innovation-led growth, with innovation revenue scaling 7x since FY21 and 80 new products launched in FY26.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| India Business Underlying Volume Growth (UVG) | 16% in Q4FY26, 13% in FY26 | Sustained double-digit UVG in India, indicating continued market penetration and demand. |
| 'Growth' Businesses Revenue Growth | 33% in Q4FY26, 24% in FY26 | Continued high growth rates in these segments to drive overall portfolio premiumization and diversification. |
| Innovation-to-Sales Ratio | 4.5% in FY26 | Maintenance or improvement of this ratio, reflecting effective new product development and market acceptance. |
| India Tea Market Share (Value) | -50 bps (MAT Mar'26 vs Mar'25) | Stabilization or recovery of market share, especially after price pass-throughs, to ensure core business strength. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 88th percentile of the scored universe and 70th percentile within FMCG. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · FMCG: 70th pctile, median 79 · Large: 74th pctile, median 73
191 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse